Information for patients
TMS and Spravato: what patients need to know
If you have been living with depression that has not responded to medications, or if side effects have made medications impossible to tolerate, TMS therapy and Spravato are two FDA approved treatments that work differently than antidepressants. This page answers the questions patients ask most before starting.
- Multidisciplinary teamNeurology, psychiatry & care coordination
- Insurance acceptedMedicare, Tricare, most major plans
- Virtual visitsTelehealth for qualifying services
- 2 locationsLong Island and Westchester, NY
- 500+ patientsTrusted by families since 2018
The two questions patients ask first
Accepting new patients
Yes, we are accepting new patients.
You can book directly — there is no pre-consult screening call. Call our office or use the appointment form at the bottom of this page. Your first appointment is a one-hour intake with Susan Mogan, PMHNP, either in-person or via telehealth.
Insurance accepted
Confirmed in-network
- Medicare
- Workers compensation
- No-fault insurance
- United Healthcare
Pending enrollment
Blue Cross Blue Shield, Aetna, Cigna, Health First, Fidelis, Medicaid, UMR, World Trade Center benefit fund
Out-of-network: Super bills available for reimbursement submission. TMS and Spravato are HSA and FSA eligible expenses.
TMS vs Spravato: what is the difference?
Both are FDA approved for treatment-resistant depression. The right choice depends on your history, your schedule, and what matters most to you in treatment. Your provider will recommend one or both after your intake evaluation.
Non-medication
TMS Therapy
- What it is
- Magnetic pulses stimulate areas of the brain involved in mood regulation
- FDA cleared for
- Depression, OCD, anxious depression
- Session length
- 20 to 40 minutes
- Frequency
- 5 sessions per week for 4 to 6 weeks
- Can I drive?
- Yes — no sedation or anesthesia
- Side effects
- Mild scalp discomfort or headache, typically diminishes after first week
- Onset
- Most patients notice improvement within 2 to 4 weeks
- Continue my medications?
- Yes — TMS can be used alongside current medications
FDA approved nasal spray
Spravato (Esketamine)
- What it is
- Esketamine nasal spray — works on NMDA receptors, different from all antidepressants
- FDA approved for
- Treatment-resistant depression, MDD with suicidal ideation
- Session length
- Self-administration plus 2-hour observation in office
- Frequency
- Twice weekly for 4 weeks (induction), then maintenance schedule
- Can I drive?
- No — you need a driver on each treatment day
- Side effects
- Dissociation, dizziness, nausea, sedation — typically resolve same day
- Onset
- Improvement as early as 24 hours after first dose
- Continue my medications?
- Not required — 2025 FDA monotherapy approval allows use without an antidepressant
How to get started
Call or book online
No pre-screening call required. Book a one-hour intake appointment directly by phone or using the form below.
Complete your intake
In-person or via telehealth with Susan Mogan, PMHNP. She reviews your history and determines whether TMS, Spravato, or another approach fits your situation.
Insurance verification
Our team handles prior authorization with your insurance carrier so you know your coverage before any treatment begins.
Telehealth available: Susan Mogan conducts virtual appointments Monday through Thursday. In-person appointments are available Tuesday and Thursday at our Aquebogue location.
Questions patients ask before starting
Book your intake appointment
Fill out the form and our team will contact you within one business day. No pre-screening call is required — this form goes directly to scheduling.
Loading form…
Medically reviewed by Dr. Susan Mogan, PMHNP, DNP, Board certified Psychiatric Mental Health Nurse Practitioner
Last reviewed: March 2026